On Nov. 19, 2013, the Indiana Biosciences Research Institute (IBRI) was initially funded with $50 million provided by the State, Lilly Endowment, Eli Lilly and Company, Roche Diagnostics, Dow AgroSciences, Indiana University Health and Indiana University School of Medicine. In 2016, IBRI received an additional $100 million in funding commitments from Lilly Endowment Inc. and Eli Lilly and Company Foundation.